Inventor

ROVINSKI BENJAMIN

CA31 patents

⚠️ This page may combine multiple inventors who share the name “ROVINSKI BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROVINSKI BENJAMIN

CONNAUGHT LAB

Antigenically-marked non-infectious retrovirus-like particles

Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles

Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers

Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies

Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region

Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences

Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains

Nucleic acids encoding for non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region

Vectors for DNA immunization against cervical cancer

Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats

Non-infectious HIV particles lacking long terminal repeats

Constitutive expression of non-infectious HIV-like particles

Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins

Immunoassay diagnostic kit containing antigens derived from self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins

AVENTIS PASTEUR

Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles

Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region

Anigenically-marked non-infectious retrovirus-like particles

Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers

Antigentically-marked non-infectious retrovirus-like particles

Retrovirus like particles made non infectious by a plurality of mutations

Constitutive expression of non-infectious HIV-like particles

Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles

Expressing gp140 fragment of primary HIV-1 isolate

SANOFI PASTEUR LTD

Modified CEA nucleic acid and expression vectors

Retrovirus-like particles made non-infectious by a plurality of mutations

Retrovirus-like particles made non-infectious by a plurality of mutations

Expressing gp140 fragment of primary HIV-1 isolate

PARRINGTON MARK

Modified CEA nucleic acid and expression vectors

Modified CEA nucleic acid and expression vectors

Modified CEA/B7 vector

ROVINSKI BENJAMIN

Nucleic acids encoding self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins